UPLIZNA
Generic: Inebilizumab
- Manufacturer
- Amgen
- NDC
- 75987-150
- RxCUI
- 2373955
- Route
- INTRAVENOUS
- ICD-10 indication
- G36.0
Affordability Check
How much will you actually pay for UPLIZNA?
In 30 seconds, see every legitimate way to afford UPLIZNA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.
About UPLIZNA
What is this medication? Uplizna is a prescription medicine used to treat neuromyelitis optica spectrum disorder, which is also known as NMOSD, in adults who are anti-aquaporin-4 antibody positive. This condition is a rare autoimmune disease that attacks the central nervous system, focusing mainly on the spinal cord and the optic nerves. The primary goal of using this treatment is to lower the risk of unpredictable relapses or attacks that can lead to cumulative neurological damage and physical disability.
The treatment works as a CD19-directed cytolytic antibody that targets and removes specific B cells from the bloodstream. These B cells are a part of the immune system that contributes to the inflammation and damage seen in patients with NMOSD. It is administered as an intravenous infusion by a medical professional, beginning with two initial loading doses followed by regular maintenance treatments every six months to help keep the disease under control.
Copay & patient assistance
- Patient Copay Amount: As little as $0 out-of-pocket for UPLIZNA and infusion costs
- Maximum Annual Benefit Limit: Not Publicly Available
- Core Eligibility Restrictions: Must be a resident of the United States with commercial insurance; not valid for patients whose prescriptions are paid in part or in full by any government-funded program (including Medicare, Medicare Part D, Medicaid, Medigap, VA, CHAMPUS, Department of Defense, or TRICARE); residents of Massachusetts or Rhode Island are not eligible for administration (infusion) support; must be prescribed for an FDA-approved indication.
- RxBIN, PCN, and Group numbers: Not Publicly Available
External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.
Compare pricing elsewhere
RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.
Cost Plus Drug Company
Mark Cuban's transparent-pricing pharmacy — manufacturer cost + 15% markup + $5 dispensing fee. No insurance needed. Search alphabetically for Inebilizumab.
Browse Cost Plus medications →
GoodRx
Compare local pharmacy prices with GoodRx coupons. Use the price with your insurance or without — whichever is cheaper.
Lookup UPLIZNA →
NeedyMeds
Independent nonprofit directory of patient assistance programs, copay cards, and charity co-pay foundations.
Search for Inebilizumab →
RxAssist
PAP directory maintained by Volunteers in Health Care at Brown University. Free, no ads.
Search PAPs →
We deep-link because transparency helps patients. None of these partners pay RxCopays.
Conditions we've indexed resources for
Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.
Prior authorization & coverage
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
Related drugs
RYSTIGGO
Treats same condition · ROZANOLIXIZUMAB
Pyridostigmine Bromide
Treats same condition · PYRIDOSTIGMINE BROMIDE
EPYSQLI
Treats same condition · Eculizumab-aagh
Protopam Chloride
Treats same condition · pralidoxime chloride
PRYIDOSTIGMINE BROMIDE
Treats same condition · Pyridostigmine Bromide
BKEMV
Treats same condition · eculizumab-aeeb
ORLYNVAH
Treats same condition · sulopenem etzadroxil and probenecid
SOLIRIS
Treats same condition · ECULIZUMAB
IMAAVY
Treats same condition · nipocalimab
Mestinon
Treats same condition · pyridostigmine bromide
How this page is sourced
- Drug identity verified against openFDA NDC Directory.
- Label text (when shown) originates from NLM DailyMed.
- Copay and assistance URLs verified periodically; if you hit a broken link, tell us.
Rare-disease navigation (specialists, trials, patient communities)
UPLIZNA treats 2 rare conditions. For in-depth disease pages on our sister site:
UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.